Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Debopam Samanta

Concepts (343)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epilepsy
32
2026
189
13.690
Why?
Anticonvulsants
20
2025
133
8.640
Why?
Seizures
24
2025
203
6.070
Why?
Tuberous Sclerosis
8
2025
38
4.170
Why?
Spasms, Infantile
11
2025
31
4.050
Why?
Cannabidiol
8
2025
44
3.860
Why?
Status Epilepticus
6
2021
33
3.200
Why?
Epilepsies, Myoclonic
5
2024
15
2.970
Why?
Mutation
16
2023
1337
2.940
Why?
Deep Brain Stimulation
4
2025
42
2.720
Why?
Humans
121
2026
53230
2.660
Why?
Electroencephalography
18
2024
305
2.400
Why?
Child
45
2026
7379
2.250
Why?
Intellectual Disability
5
2023
129
2.100
Why?
Brain
10
2024
1350
2.020
Why?
Hemiplegia
3
2021
12
1.930
Why?
Developmental Disabilities
5
2019
127
1.610
Why?
Epilepsy, Absence
3
2019
11
1.570
Why?
Magnetic Resonance Imaging
16
2025
1583
1.540
Why?
Infant
24
2025
3805
1.500
Why?
Genetic Therapy
2
2025
127
1.430
Why?
Algorithms
2
2025
667
1.350
Why?
Tumor Suppressor Proteins
3
2023
130
1.340
Why?
Neuroaxonal Dystrophies
2
2022
8
1.330
Why?
Nervous System Malformations
3
2020
17
1.330
Why?
Folate Receptor 1
2
2022
27
1.300
Why?
Child, Preschool
23
2026
4162
1.290
Why?
Infant, Newborn, Diseases
2
2020
56
1.220
Why?
Epilepsies, Partial
2
2022
15
1.220
Why?
Ketamine
2
2020
62
1.200
Why?
Vagus Nerve Stimulation
2
2025
15
1.110
Why?
Neurocutaneous Syndromes
2
2019
6
1.100
Why?
Cadherins
2
2019
62
1.080
Why?
Cerebral Arteries
2
2019
35
1.010
Why?
Male
40
2026
27435
1.000
Why?
Epilepsy, Generalized
2
2023
9
0.990
Why?
ras GTPase-Activating Proteins
1
2026
1
0.990
Why?
Vigabatrin
3
2024
3
0.980
Why?
Female
36
2026
28782
0.970
Why?
Sirolimus
2
2017
72
0.970
Why?
Tic Disorders
1
2026
4
0.960
Why?
Neurosurgical Procedures
3
2026
137
0.950
Why?
Angiofibroma
2
2015
5
0.940
Why?
Facial Neoplasms
2
2015
22
0.930
Why?
Nerve Tissue Proteins
2
2018
193
0.920
Why?
Treatment Outcome
13
2025
5595
0.910
Why?
Valproic Acid
2
2022
35
0.900
Why?
Stroke
3
2019
520
0.870
Why?
Fenfluramine
2
2024
7
0.860
Why?
Dioxolanes
2
2024
16
0.850
Why?
Thalamus
1
2024
33
0.850
Why?
Randomized Controlled Trials as Topic
2
2024
630
0.850
Why?
Pregnanolone
2
2023
6
0.830
Why?
Adolescent
18
2026
6907
0.790
Why?
Landau-Kleffner Syndrome
1
2022
3
0.780
Why?
Quality Improvement
2
2022
230
0.740
Why?
Aphasia
1
2022
37
0.730
Why?
Nervous System Diseases
2
2021
93
0.720
Why?
Chromosome Deletion
3
2019
138
0.710
Why?
Abnormalities, Multiple
3
2023
166
0.710
Why?
Phenotype
3
2026
803
0.700
Why?
Emergencies
1
2021
78
0.680
Why?
Pharmaceutical Preparations
1
2021
74
0.680
Why?
Angelman Syndrome
1
2020
1
0.670
Why?
Transition to Adult Care
1
2020
24
0.650
Why?
Bone Diseases, Developmental
2
2023
17
0.650
Why?
Tooth Abnormalities
2
2023
13
0.650
Why?
Immunoglobulins, Intravenous
1
2021
64
0.640
Why?
Oligonucleotides, Antisense
1
2020
29
0.630
Why?
Phenobarbital
1
2020
17
0.630
Why?
Immunologic Factors
1
2021
117
0.630
Why?
Flunarizine
1
2019
1
0.630
Why?
Behavioral Symptoms
1
2019
4
0.630
Why?
Excitatory Amino Acid Antagonists
1
2020
46
0.620
Why?
Ocular Physiological Phenomena
1
2019
3
0.610
Why?
Tetrasomy
1
2019
2
0.610
Why?
Agenesis of Corpus Callosum
2
2018
11
0.610
Why?
Chromosomes, Human, Pair 5
1
2019
17
0.610
Why?
Sneddon Syndrome
1
2019
3
0.610
Why?
Livedo Reticularis
1
2019
5
0.610
Why?
Calcium Channel Blockers
1
2019
57
0.610
Why?
Oral Ulcer
1
2019
3
0.600
Why?
Behcet Syndrome
1
2019
7
0.600
Why?
Transposases
1
2019
11
0.600
Why?
Andersen Syndrome
1
2019
1
0.590
Why?
Spinal Cord Diseases
1
2019
39
0.590
Why?
Hydrocephalus
1
2019
46
0.590
Why?
Receptors, GABA-B
1
2019
10
0.590
Why?
Vitiligo
1
2019
8
0.590
Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.590
Why?
Leukoencephalopathies
1
2019
15
0.580
Why?
Cytochrome-c Oxidase Deficiency
1
2018
3
0.580
Why?
Edema
1
2019
64
0.580
Why?
Migraine Disorders
2
2020
46
0.580
Why?
Cerebral Infarction
1
2018
37
0.580
Why?
Electron Transport Complex IV
1
2018
24
0.580
Why?
Physicians
1
2022
242
0.580
Why?
Optic Atrophy
1
2018
13
0.580
Why?
Muscle Weakness
1
2019
46
0.570
Why?
Nephrotic Syndrome
2
2017
35
0.570
Why?
Cannabinoid Receptor Agonists
1
2019
50
0.570
Why?
Diffuse Cerebral Sclerosis of Schilder
1
2018
8
0.570
Why?
Photic Stimulation
1
2018
56
0.570
Why?
Amino Acyl-tRNA Synthetases
1
2018
7
0.570
Why?
Alopecia
1
2019
38
0.570
Why?
Shab Potassium Channels
1
2018
2
0.570
Why?
Brain Edema
1
2018
40
0.560
Why?
Parents
1
2021
341
0.560
Why?
Thrombocytopenia
1
2019
89
0.550
Why?
Lymphohistiocytosis, Hemophagocytic
1
2018
31
0.550
Why?
Myoclonus
1
2018
9
0.550
Why?
Artifacts
1
2018
55
0.550
Why?
Autoimmune Diseases
1
2019
90
0.550
Why?
Biomedical Research
1
2021
267
0.550
Why?
Mitochondrial Diseases
1
2018
45
0.540
Why?
Neurodegenerative Diseases
1
2018
81
0.540
Why?
Practice Guidelines as Topic
1
2020
502
0.530
Why?
Osteochondrodysplasias
1
2017
14
0.520
Why?
Models, Biological
1
2020
737
0.520
Why?
Immunologic Deficiency Syndromes
1
2017
18
0.520
Why?
Hearing Loss, Sensorineural
1
2018
82
0.520
Why?
Health Knowledge, Attitudes, Practice
1
2021
523
0.510
Why?
Arteriosclerosis
1
2017
49
0.510
Why?
Carotid Artery Diseases
1
2017
33
0.510
Why?
Infant, Newborn
6
2024
2913
0.510
Why?
Drug Discovery
1
2017
94
0.500
Why?
Cafe-au-Lait Spots
1
2016
2
0.490
Why?
Child Development
1
2018
215
0.490
Why?
Skin
1
2019
419
0.480
Why?
Williams Syndrome
1
2016
25
0.480
Why?
Migraine with Aura
1
2015
4
0.480
Why?
Erythema Infectiosum
1
2015
3
0.480
Why?
Corpus Callosum
2
2023
28
0.480
Why?
Prenatal Exposure Delayed Effects
1
2018
214
0.480
Why?
Pulmonary Embolism
1
2017
83
0.480
Why?
Leukoencephalitis, Acute Hemorrhagic
1
2015
3
0.480
Why?
Syndrome
6
2024
248
0.480
Why?
Sinus Pericranii
1
2015
1
0.470
Why?
Parvovirus B19, Human
1
2015
16
0.470
Why?
Toes
1
2015
15
0.470
Why?
Electrodiagnosis
1
2015
13
0.470
Why?
SOS1 Protein
1
2015
2
0.470
Why?
Crying
1
2015
4
0.470
Why?
Moyamoya Disease
1
2015
7
0.470
Why?
Hyperventilation
1
2015
8
0.470
Why?
Iatrogenic Disease
1
2015
26
0.470
Why?
Tuberculoma
1
2015
1
0.470
Why?
Epilepsy, Benign Neonatal
1
2015
2
0.470
Why?
Noonan Syndrome
1
2015
12
0.460
Why?
Neurologic Examination
1
2015
75
0.460
Why?
Encephalitis
1
2016
40
0.460
Why?
Communication
3
2022
263
0.460
Why?
Ocular Motility Disorders
1
2015
16
0.460
Why?
Mutism
1
2015
3
0.460
Why?
NAV1.2 Voltage-Gated Sodium Channel
1
2015
3
0.460
Why?
Repressor Proteins
2
2023
149
0.450
Why?
TOR Serine-Threonine Kinases
1
2015
83
0.450
Why?
Diagnosis, Differential
7
2020
1038
0.450
Why?
Retrospective Studies
9
2026
6819
0.450
Why?
Trisomy
1
2014
34
0.440
Why?
Neurology
1
2015
33
0.440
Why?
Influenza, Human
1
2015
88
0.430
Why?
KCNQ2 Potassium Channel
1
2014
8
0.430
Why?
Energy Drinks
1
2014
6
0.430
Why?
Vasoconstriction
1
2014
55
0.430
Why?
Benzodiazepines
1
2014
72
0.420
Why?
Osteomyelitis
1
2015
134
0.420
Why?
Membrane Proteins
1
2016
333
0.410
Why?
Enzyme Inhibitors
1
2015
371
0.400
Why?
Sleep
1
2014
195
0.390
Why?
Palliative Care
2
2026
195
0.390
Why?
Quality of Life
4
2025
902
0.380
Why?
Magnetic Resonance Angiography
3
2019
72
0.380
Why?
Immunosuppressive Agents
3
2019
253
0.360
Why?
Consensus
2
2025
206
0.360
Why?
Pediatrics
1
2015
307
0.350
Why?
Receptors, N-Methyl-D-Aspartate
2
2022
79
0.330
Why?
Diffusion Magnetic Resonance Imaging
3
2017
133
0.320
Why?
Clinical Trials as Topic
2
2024
466
0.320
Why?
Caregivers
2
2021
247
0.300
Why?
Recurrence
3
2019
694
0.290
Why?
Echinocandins
1
2008
64
0.280
Why?
Mycoses
1
2008
152
0.270
Why?
Gastroesophageal Reflux
2
2019
51
0.260
Why?
Antifungal Agents
1
2008
350
0.240
Why?
Administration, Topical
2
2015
62
0.230
Why?
Adult
6
2025
14534
0.230
Why?
Seizures, Febrile
1
2024
3
0.220
Why?
Meta-Analysis as Topic
1
2024
40
0.220
Why?
Magnetoencephalography
1
2025
89
0.220
Why?
Memory, Short-Term
1
2025
74
0.220
Why?
Neuropsychological Tests
1
2026
345
0.210
Why?
Intralaminar Thalamic Nuclei
1
2024
6
0.210
Why?
Animals
4
2026
13526
0.210
Why?
Psychosurgery
1
2023
5
0.210
Why?
Databases, Factual
2
2024
742
0.210
Why?
Comorbidity
1
2026
638
0.200
Why?
Laser Therapy
1
2023
75
0.200
Why?
Speech Disorders
1
2022
16
0.190
Why?
Ethosuximide
1
2022
5
0.190
Why?
Clonazepam
1
2022
6
0.190
Why?
Cluster Analysis
1
2023
237
0.190
Why?
Electrodes, Implanted
1
2022
36
0.190
Why?
Stereotaxic Techniques
1
2022
41
0.190
Why?
Death, Sudden
1
2022
9
0.190
Why?
GTPase-Activating Proteins
1
2022
25
0.180
Why?
Concept Formation
1
2021
13
0.180
Why?
Perivascular Epithelioid Cell Neoplasms
1
2021
4
0.180
Why?
Freedom
1
2021
3
0.180
Why?
Folic Acid
1
2022
137
0.180
Why?
Diazepam
1
2021
18
0.180
Why?
Drug Interactions
1
2022
196
0.170
Why?
Fibroma
1
2021
41
0.170
Why?
Adrenocorticotropic Hormone
2
2022
32
0.170
Why?
Personal Satisfaction
1
2021
76
0.170
Why?
Soft Tissue Neoplasms
1
2021
62
0.170
Why?
Risk Factors
2
2020
4017
0.170
Why?
Dihydroergotamine
1
2020
5
0.170
Why?
Brain Diseases
1
2021
85
0.170
Why?
Transcription Factors
2
2023
571
0.160
Why?
Perception
1
2021
124
0.160
Why?
Facies
2
2023
36
0.160
Why?
Mental Disorders
1
2025
446
0.160
Why?
Diet Therapy
1
2020
8
0.160
Why?
Genetic Diseases, Inborn
1
2020
23
0.160
Why?
Clinical Protocols
1
2020
109
0.160
Why?
Treatment Failure
1
2020
119
0.160
Why?
Anesthetics
1
2020
38
0.160
Why?
Learning
1
2021
156
0.150
Why?
Leukomalacia, Periventricular
1
2019
12
0.150
Why?
Muscle Hypotonia
1
2019
23
0.150
Why?
Chromosomes, Human, Pair 7
1
2019
29
0.150
Why?
Matrix Attachment Region Binding Proteins
1
2020
38
0.150
Why?
HLA-B51 Antigen
1
2019
2
0.150
Why?
Ventriculoperitoneal Shunt
1
2019
29
0.150
Why?
Analgesics, Non-Narcotic
1
2020
120
0.150
Why?
Craniofacial Abnormalities
1
2019
27
0.150
Why?
Patient-Centered Care
1
2021
141
0.150
Why?
Ubiquitin-Protein Ligases
1
2020
140
0.150
Why?
Qualitative Research
1
2021
384
0.150
Why?
Heart Septal Defects, Atrial
1
2019
45
0.150
Why?
Disease Management
1
2020
187
0.150
Why?
Potassium Channels, Inwardly Rectifying
1
2019
7
0.150
Why?
Ventricular Premature Complexes
1
2019
7
0.150
Why?
Microcephaly
1
2019
40
0.150
Why?
Melkersson-Rosenthal Syndrome
1
2018
4
0.150
Why?
Facial Nerve Diseases
1
2018
6
0.150
Why?
Syncope
1
2019
31
0.140
Why?
Referral and Consultation
1
2021
299
0.140
Why?
Nocturnal Myoclonus Syndrome
1
2018
13
0.140
Why?
Cerebral Veins
1
2018
17
0.140
Why?
Facial Paralysis
1
2018
25
0.140
Why?
Anti-Arrhythmia Agents
1
2019
79
0.140
Why?
Deglutition Disorders
1
2019
76
0.140
Why?
Health Personnel
1
2021
259
0.140
Why?
Fatal Outcome
1
2019
193
0.140
Why?
Acute Disease
1
2019
393
0.140
Why?
Fibrinolytic Agents
1
2019
132
0.140
Why?
Frameshift Mutation
1
2018
18
0.140
Why?
Video Recording
1
2018
81
0.140
Why?
Combined Modality Therapy
1
2020
640
0.140
Why?
Anti-Inflammatory Agents
1
2019
164
0.140
Why?
Fear
1
2018
85
0.140
Why?
India
1
2017
59
0.130
Why?
Cerebellum
1
2018
121
0.130
Why?
History, 21st Century
1
2017
60
0.130
Why?
Platelet Aggregation Inhibitors
1
2019
213
0.130
Why?
History, 20th Century
1
2017
97
0.130
Why?
Neurotoxicity Syndromes
1
2017
46
0.130
Why?
Methotrexate
1
2017
78
0.130
Why?
Pandemics
1
2021
595
0.130
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
92
0.120
Why?
Anti-Infective Agents
1
2017
107
0.120
Why?
Aldehyde Dehydrogenase
1
2016
24
0.120
Why?
Influenza B virus
1
2015
6
0.120
Why?
Hormones
1
2016
58
0.120
Why?
Delayed Diagnosis
1
2016
29
0.120
Why?
Chromosomes, Human, Pair 3
1
2015
18
0.120
Why?
Arkansas
1
2021
2068
0.120
Why?
North America
1
2015
75
0.120
Why?
Cerebral Angiography
1
2015
94
0.110
Why?
Complementary Therapies
1
2015
23
0.110
Why?
Antibiotics, Antineoplastic
1
2015
83
0.110
Why?
Chromosomes, Human, Pair 9
1
2014
20
0.110
Why?
Brain Waves
1
2014
19
0.110
Why?
Drug Resistance
1
2015
71
0.110
Why?
Polymerase Chain Reaction
1
2015
452
0.110
Why?
Antiemetics
1
2014
32
0.110
Why?
Headache
1
2014
75
0.100
Why?
Glutamine
1
2015
177
0.100
Why?
Vomiting
1
2014
71
0.100
Why?
Mutation, Missense
1
2014
110
0.100
Why?
Arginine
1
2015
178
0.100
Why?
Analgesics
1
2014
104
0.100
Why?
Decision Making, Computer-Assisted
1
2013
3
0.100
Why?
Diagnostic Errors
1
2013
68
0.100
Why?
Evidence-Based Medicine
1
2013
275
0.090
Why?
Inflammation
1
2016
652
0.090
Why?
Pregnancy
1
2018
2608
0.090
Why?
Signal Transduction
1
2017
1748
0.080
Why?
Antineoplastic Agents
1
2017
1232
0.070
Why?
Dysentery
1
2009
1
0.070
Why?
Trichuriasis
1
2009
1
0.070
Why?
Trichuris
1
2009
1
0.070
Why?
Anesthesia, Intravenous
1
2008
12
0.070
Why?
Eosinophils
1
2009
40
0.070
Why?
Lipopeptides
1
2008
62
0.070
Why?
Amyloidosis
1
2009
83
0.070
Why?
Tuberculosis
1
2009
133
0.070
Why?
Candidiasis
1
2008
114
0.070
Why?
Aspergillosis
1
2008
122
0.070
Why?
Inflammatory Bowel Diseases
1
2009
88
0.070
Why?
Kidney Diseases
1
2009
230
0.060
Why?
Prospective Studies
2
2023
2411
0.060
Why?
Clinical Trials, Phase III as Topic
1
2025
48
0.060
Why?
Observer Variation
1
2024
138
0.050
Why?
Spasm
1
2024
9
0.050
Why?
Feedback
1
2024
53
0.050
Why?
Kaplan-Meier Estimate
1
2025
487
0.050
Why?
Probability
1
2023
171
0.050
Why?
Neuroimaging
1
2023
95
0.050
Why?
Pilot Projects
1
2025
726
0.050
Why?
Young Adult
2
2025
4511
0.050
Why?
Cohort Studies
1
2026
1557
0.040
Why?
Potassium Channels
1
2021
32
0.040
Why?
Reproducibility of Results
1
2024
1219
0.040
Why?
Registries
1
2024
652
0.040
Why?
Administration, Intravenous
1
2020
73
0.040
Why?
Sleep Stages
1
2020
42
0.040
Why?
Age of Onset
1
2020
109
0.040
Why?
Cognition
1
2022
346
0.040
Why?
Follow-Up Studies
1
2025
2318
0.040
Why?
Immunohistochemistry
1
2021
975
0.040
Why?
Aged
1
2025
10429
0.020
Why?
Software
1
2013
280
0.020
Why?
Internet
1
2013
265
0.020
Why?
Middle Aged
1
2025
13419
0.020
Why?
Mebendazole
1
2009
2
0.020
Why?
Antinematodal Agents
1
2009
3
0.020
Why?
Leukemoid Reaction
1
2009
6
0.020
Why?
Antitubercular Agents
1
2009
89
0.020
Why?
Colonoscopy
1
2009
107
0.020
Why?
Prognosis
1
2009
2118
0.010
Why?
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description